logo
Medical news
of the North Caucasus
Scientific journal
Mass media registration certificate dated December 7, 2006.
Series ПИ #ФС 77-26521.
Federal service for surveillance over non-violation of the legislation in the sphere of mass communications and protection of cultural heritage.
ISSN 2073-8137
rus
русский
eng
english

Site search



Correspondence address
310 Mira Street, Stavropol, Russia, 355017

Tel
+7 8652 352524; +7 8652 353229.

Fax
+7 8652 352524.

E-mail
medvestnik@stgmu.ru

Photodynamic adjuvant therapy in complex treatment of patients with portal cholangiocarcinoma

[Review]
Yuri Zharikov; Anastasia Pozharskaya; Kirill Tupikin; Marina Baidarova; Vladimir Nikolenko;

The review presents the latest achievements in the field of complex adjuvant treatment of patients with portal cholangiocarcinoma. Modern data on the clinical efficacy and benefits of intraduct photodynamic therapy are presented.

Download

References:
1. Horgan A. M., Amir E., Walter T., Knox J. J. Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis. J. Clin. Oncol. 2012;30(16):1934- 1940. https://doi.org/10.1200/JCO.2011.40.5381
2. Mansour J. C., Aloia T. A., Crane C. H., Heimbach J. K., Nagino M., Vauthey J. N. Hilar cholangiocarcinoma: expert consensus statement. HPB (Oxford). 2015;17(8):691- 699. https://doi.org/10.1111/hpb.12450
3. Shiryaev A. A., Musaev G. Kh., Loshchenov M. V., Borodkin A. V., Levkin V. V. Combined Minimally Invasive Treatment of Cholangiocellular Cancer Complicated by Obstructive Jaundice. Intraductal Videofluorescent Diagnostics – the First Experience in Russia. Annaly khirurgicheskoy gepatologii. – Annals of Surgical Hepatology. 2017;22(1):71-81. (In Russ.).
4. Jarnagin W. R., Fong Y., DeMatteo R. P., Gonen M., Burke E. C. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann. Surg. 2001;234:507-517.
5. Groot Koerkamp B., Wiggers J. K., Gonen M., Doussot A., Allen P. J. Survival after resection of perihilar cholangiocarcinoma- development and external validation of a prognostic nomogram. Ann. Oncol. 2015;26(9):1930- 1935. https://doi.org/10.1093/annonc/mdv279
6. Popescu I., Dumitrascu T. Curative-intent surgery for hilar cholangiocarcinoma: prognostic factors for clinical decision making. Langenbecks. Arch. Surg. 2014;399(6):693- 705. https://doi.org/10.1007/s00423-014-1210-x
7. Ben-Josef E., Guthrie K. A., El-Khoueiry A. B., Corless C. L., Zalupski M. M. [et al.]. SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma. J. Clin. Oncol. 2015;33(24):2617-2622. https://doi.org/10.1200/JCO.2014.60.2219
8. Skipworth J. R., Olde Damink S. W., Imber C., Bridgewater J., Pereira S. P., Malagó M. Review article: surgical, neo-adjuvant and adjuvant management strategies in biliary tract cancer. Aliment. Pharmacol. Ther. 2011;34(9):1063-1078. https://doi.org/10.1111/j.1365-2036.2011.04851.x
9. Wiedmann M., Caca K., Berr F., Schiefke I., Tannapfel A. [et al.]. Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: a phase II pilot study. Cancer. 2003;97(11):2783-2790. https://doi.org/10.1002/cncr.11401
10. Бредер В. В. Рак желчевыводящей системы. Практическая онкология. 2012;13(4):269-275. [Breder V. V. Cancer biliary system. Prakticheskaya onkologiya. – Practical Oncology. 2012;13(4):269-275. (In Russ.)].
11. Cidon E. U. Resectable Cholangiocarcinoma: Reviewing the Role of Adjuvant Strategies. Clin. Med. Insights. Oncol. 2016;(10):43-48. https://doi.org/10.4137/CMO.S32821
12. Makarov Ye. S., Nechushkin M. I., Dolgushin B. I., Kukushkin A. V., Molodikova N. R., Kozlov O. V. Intraductal Radiotherapy in Patients with Inoperable Cholangiocarcinoma. Technical Aspects and Long-Term Outcomes. Annaly khirurgicheskoy gepatologii. – Annals of Surgical Hepatology. 2014;19(4):48- 55. (In Russ.).
13. Makarov E. S., Nechushkin M. I., Kukushkin A. V., Molodikova N. R. Intraluminal Radiotherapy in Combined Treatment of Patients with Klatskin Tumors. Annaly khirurgicheskoy gepatologii. – Annals of Surgical Hepatology. 2013;18(2):50-60. (In Russ.).
14. Gelfond M. L. Photodynamic therapy in oncology. Prakticheskaya onkologiya. – Practical Oncology. 2007;8(4):204-210. (In Russ.).
15. Huang Z., Xu H., Meyers A. D., Musani A. I., Wang L., Tagg R., Barqawi A. B., Chen Y. K. Photodynamic therapy for treatment of solid tumors-potential and technical challenges. Technol. Cancer. Res. Treat. 2008;7(4):309-320. https://doi.org/10.1177/153303460800700405
16. Tomizawa Y., Tian J. Photodynamic therapy for unresectable cholangiocarcinoma. Dig. Dis. Sci. 2012;57(2):274-283. https://doi.org/10.1007/s10620-011-1957-7
17. Dolgushin B. I., Sergeeva O. N., Frantsev D. Y., Kukushkin A. V., Panov V. O. [et al.]. Intraductal Photodynamic Therapy of Hilar Cholangiocarcinoma in Inoperable Patients. Annaly khirurgicheskoy gepatologii. – Annals of Surgical Hepatology. 2016;21(3):106-118. (In Russ.).
18. Witzigmann H., Berr F., Ringel U., Caca K., Uhlmann D. [et al.]. Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/ r2 resection. Ann. Surg. 2006;244(2):230-239. https://doi.org/10.1097/01.sla.0000217639.10331.47
19. Höblinger A., Gerhardt T., Gonzalez-Carmona M. A., Hüneburg R., Sauerbruch T., Schmitz V. Feasibility and safety of long-term photodynamic therapy (PDT) in the palliative treatment of patients with hilar cholangiocarcinoma. Eur. J. Med. Res. 2011;16(9):391- 395.
20. Wentrup R., Winkelmann N., Mitroshkin A., Prager M., Voderholzer W., Schachschal G., Jürgensen C., Büning C. Photodynamic Therapy Plus Chemotherapy Compared with Photodynamic Therapy Alone in Hilar Nonresectable Cholangiocarcinoma. Gut. Liver. 2016;10(3):470-475. https://doi.org/10.5009/gnl15175
21. Ulaschik V. S. Photodynamic therapy: A technology of the XXI-st century. Fizioterapiya, balneologiya i reabilitatsiya. – Russian Journal of Physiotherapy, Balneology and Rehabilitation. 2013;1:36-43. (In Russ.)
22. Lee T. Y., Cheon Y. K., Shim C. S. Current status of photodynamic therapy for bile duct cancer. Clin. Endosc. 2013;46(1):38-44. https://doi.org/10.5946/ce.2013.46.1.38
23. Nanashima A., Yamaguchi H., Shibasaki S., Ide N., Sawai T. [et al.]. Adjuvant photodynamic therapy for bile duct carcinoma after surgery: a preliminary study. J. Gastroenterol. 2004;39(11):1095-1101. https://doi.org/10.1007/s00535-004-1449-z
24. Wagner A., Wiedmann M., Tannapfel A., Mayr C., Kiesslich T. [et al.]. Neoadjuvant Down-Sizing of Hilar Cholangiocarcinoma with Photodynamic Therapy- Long-Term Outcome of a Phase II Pilot Study. Int. J. Mol. Sci. 2015;16(11):26619-26628. https://doi.org/10.3390/ijms161125978
25. Moole H., Tathireddy H., Dharmapuri S., Moole V., Boddireddy R. [et al.]. Success of photodynamic therapy in palliating patients with nonresectable cholangiocarcinoma: A systematic review and metaanalysis. World J. Gastroenterol. 2017;23(7):1278-1288. https://doi.org/10.3748/wjg.v23.i7.1278

Keywords: portal cholangiocarcinoma, intraduct photodynamic therapy, prognosis


Founders:
Stavropol State Medical Academy
Pyatigorsk State Research Institute of Balneotherapeutics
Pyatigorsk State Pharmaceutical Academy